All View

Product Information
Registration Number BR-1046
Generic Name Insulin Glulisine
Brand Name Apidra
Dosage Strength 3.49 mg/mL (equivalent to 100 Units/mL)
Dosage Form Solution for Subcutaneous/Continuous SC Pump Infusion/ Intravenous Injection
Classification Prescription Drug (RX)
Packaging 10 mL Type I Colorless Glass Vial (Box of 1's)
Pharmacologic Category -
Manufacturer Sanofi-Aventis Deutschland GmbH
Country of Origin Germany
Importer Sanofi-Aventis Philippines, Inc.
Distributor Sanofi-Aventis Philippines, Inc.
Application Type -
Issuance Date 26 February 2021
Expiry Date 28 October 2025